These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4598138)
21. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
22. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria. Pattyn SR; Portaels F; Van Loo G; Van den Breen L Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011 [TBL] [Abstract][Full Text] [Related]
23. The impact of experimental human leprosy in the mouse on leprosy research. Rees RJ Int J Lepr Other Mycobact Dis; 1971; 39(2):201-15. PubMed ID: 4948076 [No Abstract] [Full Text] [Related]
24. Primary dapsone-resistant leprosy in Cebu, Philippines. Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607 [TBL] [Abstract][Full Text] [Related]
27. [Current data on the bacteriology of leprosy]. Grosset J; Guelpa-Lauras CC; Lecoeur H Acta Leprol; 1982; (86-87):35-45. PubMed ID: 6815996 [TBL] [Abstract][Full Text] [Related]
28. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
29. [Leprosy as a mycobacterial disease and its control in Cuba]. Werner E Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug; 135(1):113-21. PubMed ID: 4941062 [No Abstract] [Full Text] [Related]
30. The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Richardus JH; Habbema JD Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706 [TBL] [Abstract][Full Text] [Related]
31. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses. Browne SG Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048 [No Abstract] [Full Text] [Related]
32. Beige mice infected with Mycobacterium leprae. Gelber RH; Scollard DM; Cynamon MH Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):295-7. PubMed ID: 7602228 [No Abstract] [Full Text] [Related]
33. [On the diagnosis and differential diagnosis of individual leprosy cases based on 5 cases observed in Zurich]. Storck H; Schwarz K Schweiz Med Wochenschr; 1967 Mar; 97(10):297-303. PubMed ID: 4869517 [No Abstract] [Full Text] [Related]
34. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five? Kumarasinghe SP; Kumarasinghe MP Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583 [No Abstract] [Full Text] [Related]
35. A overview of ocular leprosy after 2 decades of multidrug therapy. Lewallen S; Courtright P Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278 [No Abstract] [Full Text] [Related]
36. Progress in leprosy research. WHO Chron; 1966 Mar; 20(3):98-100. PubMed ID: 5325357 [No Abstract] [Full Text] [Related]
37. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
39. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]
40. At twenty years after Shepard's method of inoculation of M. leprae in the foot pads of mice. Bergel M Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):67-8. PubMed ID: 6988350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]